Goldman Sachs’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,397,403
Closed -$52.6M 5820
2021
Q1
$52.6M Buy
1,397,403
+1,171,542
+519% +$44.1M 0.01% 1005
2020
Q4
$3.84M Buy
225,861
+68,962
+44% +$1.17M ﹤0.01% 2632
2020
Q3
$737K Sell
156,899
-8,314
-5% -$39.1K ﹤0.01% 3481
2020
Q2
$1.01M Buy
165,213
+115,767
+234% +$706K ﹤0.01% 3222
2020
Q1
$112K Sell
49,446
-37,646
-43% -$85.3K ﹤0.01% 4141
2019
Q4
$400K Buy
87,092
+1,083
+1% +$4.97K ﹤0.01% 3755
2019
Q3
$333K Sell
86,009
-165,075
-66% -$639K ﹤0.01% 3746
2019
Q2
$1.51M Buy
251,084
+122,360
+95% +$738K ﹤0.01% 2957
2019
Q1
$1.73M Sell
128,724
-546
-0.4% -$7.32K ﹤0.01% 3014
2018
Q4
$1.2M Sell
129,270
-69,471
-35% -$647K ﹤0.01% 3057
2018
Q3
$2.77M Buy
198,741
+8,569
+5% +$119K ﹤0.01% 2719
2018
Q2
$3.01M Sell
190,172
-40,003
-17% -$633K ﹤0.01% 2673
2018
Q1
$3.95M Buy
230,175
+76,875
+50% +$1.32M ﹤0.01% 2480
2017
Q4
$3.36M Buy
153,300
+90,810
+145% +$1.99M ﹤0.01% 2534
2017
Q3
$2.56M Sell
62,490
-144,108
-70% -$5.89M ﹤0.01% 2742
2017
Q2
$6.22M Sell
206,598
-10,864
-5% -$327K ﹤0.01% 2161
2017
Q1
$7.86M Buy
217,462
+127,693
+142% +$4.62M ﹤0.01% 1959
2016
Q4
$4.5M Sell
89,769
-564,583
-86% -$28.3M ﹤0.01% 2244
2016
Q3
$34.3M Buy
654,352
+474,011
+263% +$24.9M 0.01% 1178
2016
Q2
$7.46M Buy
180,341
+92,781
+106% +$3.84M ﹤0.01% 1927
2016
Q1
$3.56M Sell
87,560
-92,278
-51% -$3.75M ﹤0.01% 2240
2015
Q4
$7.46M Buy
179,838
+142,719
+384% +$5.92M ﹤0.01% 1832
2015
Q3
$571K Sell
37,119
-6,580
-15% -$101K ﹤0.01% 3220
2015
Q2
$1.09M Buy
43,699
+23,630
+118% +$587K ﹤0.01% 2917
2015
Q1
$459K Buy
20,069
+9,549
+91% +$218K ﹤0.01% 3367
2014
Q4
$284K Sell
10,520
-463,852
-98% -$12.5M ﹤0.01% 3742
2014
Q3
$5.56M Sell
474,372
-32,417
-6% -$380K ﹤0.01% 1917
2014
Q2
$7.88M Buy
506,789
+3,497
+0.7% +$54.4K ﹤0.01% 1735
2014
Q1
$9.9M Buy
503,292
+24,326
+5% +$478K ﹤0.01% 1596
2013
Q4
$8.04M Buy
+478,966
New +$8.04M ﹤0.01% 1698